Induction of matrix metalloproteinase gene expression in an endothelial cell line by direct interaction with malignant cells

Cancer Science

Volumn 98, Issue 1, 2007, Pages 58-67

  Hasebe, Yuki ^a   Egawa, Kiyoshi ^a   Shibanuma, Motoko ^a   Nose, Kiyoshi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; REACTIVE OXYGEN METABOLITE; STROMELYSIN; STROMELYSIN 2;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL INTERACTION; CELL LINE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FIBROBLASTS; FREE RADICAL SCAVENGERS; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASES; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; NEOPLASM METASTASIS; NEOPLASMS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33751337541     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00344.x     Document Type: Article

References (48)

1. Bogenrieder T, Herlyn M. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 2003; 22: 6524-36.
2. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000; 190: 310-29.
3. Elices MJ, Osborn L, Takada Y et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577-84.
4. Haraldsen G, Kvale D, Lien B et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 1996; 156: 2558-65.
5. Garofalo A, Chirivi RG, Foglieni C et.al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 1995; 55: 414-19.
6. Oshima T, Blaschuk O, Gour B et.al. Tight junction peptide antagonists enhance neutrophil trans-endothelial chemotaxis. Life Sci 2003; 73: 1729-40.
7. Muller WA, Randolph GJ. Migration of leukocytes across endothelium and beyond: Molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 1999; 66: 698-704.
8. Westerlund A, Hujanen E, Puistola U, Turpeenniemi-Hujanen T. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol Oncol 1997; 67: 76-82.
9. Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastas 1998; 16: 169-77.
10. Bair EL, Massey CP, Tran NL et.al. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res 2001; 270: 259-67.
11. Jodele S, Chantrain CF, Blavier L et al. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 2005; 65: 3200-8.
12. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002; 70: 561-73.
13. Egeblad M, Werb A. New functions for the matrix metalloproteinases in cancer progression. Nature Rev Cancer 2002; 2: 161-74.
14. Seiki M. The cell surface: The stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 2002; 14: 624-32.
15. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005; 1755: 37-69.
16. Liabakk NB, Talbot I, Smith RA et al. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996; 56: 190-6.
17. Taraboletti G, D'Ascenzo S, Borsotti P et.al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002; 160: 673-80.
18. Yanai N, Satoh T, Kyo S, Abe K, Suzuki M, Obinata M. A tubule cell line established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. Jpn J Cancer Res 1991; 82: 1344-8.
19. Ishino K, Kaneyama J-K, Shibanuma M, Nose K. Specific decrease in the level of Hic-5, a focal adhesion protein, during immortalization of mouse embryonic fibroblasts, and its association with focal adhesion kinase. J Cell Biochem 2000; 76: 411-19.
20. Jimenz C, Jones DR, Rodriguerz-Viciana P et.al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 1998; 17: 743-53.
21. Kennedy ED, Maechler P, Wollheim CB. Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes 1998; 47: 374-80.
22. Tanaka H, Matsumura I, Ezoe S et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-B activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 2002; 9: 1017-29.
23. Ruhul Amin AR, Senga T, Oo ML et.al. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1β: A role for the dual signalling pathways, Akt and Erk. Genes Cells 2003; 8: 515-23.
24. Johansson N, Ala-aho R, Uitto V et al. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000; 113 (Part 2): 227-35.
25. Yao J, Xiong S, Klos K et al. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells. Oncogene 2001; 20: 8066-74.
26. Yang L, Dan HC, Sun M et al. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 2004; 64: 4394-9.
27. Matheny HE, Deem T, Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol 2000; 164: 6550-9.
28. Tudor KS, Hess KL, Cook-Mills JM. Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine 2001; 15: 196-211.
29. van Wetering S, van Buul JD, Quik S et al. Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 2002; 115: 1837-46.
30. Zhang G, Miura Y, Yagasaki K. Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 2000; 159: 169-73.
31. Lim HW, Hong S, Jin W et.al. Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells. Exp Mol Med, 2005; 37: 497-506.
32. Overall CM, Lüpez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002; 2: 657-72.
33. Danen EHJ, Yamada K. Fibronectin, integrins, and growth control. J Cell Physiol 2001; 189: 1-13.
34. Holzmann B, Gosslar U, Bittner M. Alpha 4 integrins and tumor metastasis. Curr Top Microbiol Immuno 1998; 231: 125-41.
35. Vihinen P, Riikonen T, Laine A, Heino J. Integrin α2β1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen. Cell Growth Differ 1996; 7: 439-47.
36. Alon R, Feigelson SW, Manevich E et al. Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the α4-cytoplasmic domain. J Cell Biol 2005; 171: 1073-84.
37. Moshal KS, Sen U, Tyagi N et al. Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol 2006; 290: C883-91.
38. Iyer V, Pumiglia K, DiPersio CM. Alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: A novel mechanism of integrin-mediated MMP gene expression. J Cell Sci 2005; 118: 1185-95.
39. Shin I, Kim S, Song H, Kim HR, Moon A. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: Its critical role in invasion and migration of breast epithelial cells. J Biol Chem 2005; 280: 14 675-83.
40. 2+ - or PI3K-dependent signaling pathway in a human vascular endothelial cell line. FEBS Lett 2005; 579: 6451-8.
41. Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF, Livant DL. Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res 2006; 66: 8091-9.
42. Heit B, Colarusso P, Kubes P. Fundamentally different roles for LFA-1, Mac-1 and α4-integrin in neutrophil chemotaxis. J Cell Sci 2005; 118: 5205-20.
43. Wallace DC. Mitochondria and cancer: Warburg addressed. Cold Spring Harb Symp Quant Biol 2005; 70: 363-74.
44. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nature Rev Cancer 2002; 2: 489-501.
45. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998; 10: 248-53.
46. Nose K. Redox control of protein trafficking. Antioxidants Redox Signaling 2005; 7: 303-7.
47. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 2004; 37: 768-84.
48. Woo CH, Lim JH, Kim JH. Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J Immunol 2004; 173: 6973-80.